2NYT image
Deposition Date 2006-11-21
Release Date 2007-01-09
Last Version Date 2023-12-27
Entry Detail
PDB ID:
2NYT
Keywords:
Title:
The APOBEC2 Crystal Structure and Functional Implications for AID
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.29
R-Value Work:
0.24
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Probable C->U-editing enzyme APOBEC-2
Gene (Uniprot):APOBEC2
Chain IDs:A, B, C, D
Chain Length:190
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
The APOBEC-2 crystal structure and functional implications for the deaminase AID.
Nature 445 447 451 (2007)
PMID: 17187054 DOI: 10.1038/nature05492

Abstact

APOBEC-2 (APO2) belongs to the family of apolipoprotein B messenger RNA-editing enzyme catalytic (APOBEC) polypeptides, which deaminates mRNA and single-stranded DNA. Different APOBEC members use the same deamination activity to achieve diverse human biological functions. Deamination by an APOBEC protein called activation-induced cytidine deaminase (AID) is critical for generating high-affinity antibodies, and deamination by APOBEC-3 proteins can inhibit retrotransposons and the replication of retroviruses such as human immunodeficiency virus and hepatitis B virus. Here we report the crystal structure of APO2. APO2 forms a rod-shaped tetramer that differs markedly from the square-shaped tetramer of the free nucleotide cytidine deaminase, with which APOBEC proteins share considerable sequence homology. In APO2, two long alpha-helices of a monomer structure prevent the formation of a square-shaped tetramer and facilitate formation of the rod-shaped tetramer via head-to-head interactions of two APO2 dimers. Extensive sequence homology among APOBEC family members allows us to test APO2 structure-based predictions using AID. We show that AID deamination activity is impaired by mutations predicted to interfere with oligomerization and substrate access. The structure suggests how mutations in patients with hyper-IgM-2 syndrome inactivate AID, resulting in defective antibody maturation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures